Fulton Bank, N.A. Amicus Therapeutics, Inc. Transaction History
Fulton Bank, N.A.
- $1.12 Billion
- Q2 2024
A detailed history of Fulton Bank, N.A. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 10,257 shares of FOLD stock, worth $108,313. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,257
Previous 10,257
-0.0%
Holding current value
$108,313
Previous $120,000
15.83%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding FOLD
# of Institutions
277Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$302 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$296 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$289 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$257 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$223 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...